While the precise role of some molecules (including BTNL9) requires further investigation, the currently established organoid- γδ T cell co-culture system should prove useful for testing additional modulators (e.g. small molecules, antibodies, tumour sensitizers, etc.)with the ultimate goal of improving the efficacy of γδ T cell immunotherapy for cervical cancer. The gene discussed is BTNL9; the disease is neoplasm.